Research Fellows

Xinan Wang

Postdoctoral Research Fellow

Environmental Health

xinanwang@hsph.harvard.edu


Overview

B.S., 03.2016, Biomedical Engineering
Tokyo Institute of Technology , Tokyo

Ph.D., 03.2022, Population Health Sciences
Harvard University, Boston

M.S., 05.2018, Computational Biology and Quantitative Genetics
Harvard T.H. Chan School of Public Health, Boston

Harvard Presidential Scholarship2018-2019
Harvard University


Bibliography

Diminished Efficacy of Programmed Death-(Ligand)1 Inhibition in STK11- and KEAP1-Mutant Lung Adenocarcinoma Is Affected by KRAS Mutation Status.

Ricciuti B, Arbour KC, Lin JJ, Vajdi A, Vokes N, Hong L, Zhang J, Tolstorukov MY, Li YY, Spurr LF, Cherniack AD, Recondo G, Lamberti G, Wang X, Venkatraman D, Alessi JV, Vaz VR, Rizvi H, Egger J, Plodkowski AJ, Khosrowjerdi S, Digumarthy S, Park H, Vaz N, Nishino M, Sholl LM, Barbie D, Altan M, Heymach JV, Skoulidis F, Gainor JF, Hellmann MD, Awad MM.

J Thorac Oncol. 2022 03. 17(3):399-410. PMID: 34740862